Search

everythinglearnresearchcommunity

for

Search:↓

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Hair loss in androgenetic alopecia may be due to ongoing tiny inflammation and tissue changes around hair follicles.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

Excessive androgens in women with polycystic ovary syndrome can lead to excessive hair growth and hair loss, but this might not fully explain these conditions.

Androgenetic alopecia is a common type of hair loss in men and women, caused by a testosterone byproduct affecting hair follicles, with sensitivity determined by genetics.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Testosterone helps beard and axillary hair cells grow by releasing growth factors from dermal papilla cells.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

TrichoScan helps identify subtle hair thinning in women with androgenetic alopecia.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

5α-reductase inhibitors like finasteride and dutasteride can help treat skin disorders stimulated by androgens, such as hair loss and acne.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

Minoxidil can reduce functions related to androgen receptors.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

A specific pathway involving AR, miR-221, and IGF-1 plays a key role in causing common hair loss.

Connarus semidecandrus Jack extract promotes hair growth and thickness, reduces prostate cancer cell growth, and could potentially be used as a treatment for hair loss.

Dexamethasone increases the activity of androgen receptors in human skin cells, which may link it to certain types of hair loss.

Noni fruit extract, specifically the FEA-3 sub-fraction, can increase hair growth and reduce baldness in male rabbits, potentially acting like common hair loss treatments.

The study found that androgen receptors in skin cells mainly affect the focal adhesion pathway and control the caveolin-1 gene, with implications for new treatments for related diseases.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Hair RiseTM microemulsion effectively promotes hair growth and treats hair loss better than standard treatments.

Adenosine complex helps increase hair thickness and density in hair loss.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.